These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 11240417

  • 1. [Statins and unstable angina: MIRACL].
    Puel J.
    Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 2):145-8. PubMed ID: 11240417
    [Abstract] [Full Text] [Related]

  • 2. Rationale and design of the Myocardial Ischemia Reduction With Aggressive Cholesterol lowering (MIRACL) Study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction.
    Ghali JK.
    Am J Cardiol; 1998 Sep 01; 82(5):703. PubMed ID: 9732912
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Acute statin treatment in reducing risk after acute coronary syndrome: the MIRACL (Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering) Trial.
    Ahsan CH, Shah A, Ezekowitz M.
    Curr Opin Cardiol; 2001 Nov 01; 16(6):390-3. PubMed ID: 11704711
    [Abstract] [Full Text] [Related]

  • 5. Rationale and design of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction.
    Schwartz GG, Oliver MF, Ezekowitz MD, Ganz P, Waters D, Kane JP, Texter M, Pressler ML, Black D, Chaitman BR, Olsson AG.
    Am J Cardiol; 1998 Mar 01; 81(5):578-81. PubMed ID: 9514453
    [Abstract] [Full Text] [Related]

  • 6. Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy.
    Waters DD, Schwartz GG, Olsson AG, Zeiher A, Oliver MF, Ganz P, Ezekowitz M, Chaitman BR, Leslie SJ, Stern T, MIRACL Study Investigators.
    Circulation; 2002 Sep 24; 106(13):1690-5. PubMed ID: 12270864
    [Abstract] [Full Text] [Related]

  • 7. Anti-inflammatory effect of atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction.
    Correia LC, Spósito AC, Lima JC, Magalhães LP, Passos LC, Rocha MS, D'Oliveira A, Esteves JP.
    Am J Cardiol; 2003 Aug 01; 92(3):298-301. PubMed ID: 12888137
    [Abstract] [Full Text] [Related]

  • 8. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
    Kinlay S, Schwartz GG, Olsson AG, Rifai N, Leslie SJ, Sasiela WJ, Szarek M, Libby P, Ganz P, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators.
    Circulation; 2003 Sep 30; 108(13):1560-6. PubMed ID: 12975259
    [Abstract] [Full Text] [Related]

  • 9. [Meeting report. "MIRACL" study of "Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering"].
    Scheen AJ.
    Rev Med Liege; 2000 Dec 30; 55(12):1064-6. PubMed ID: 11205194
    [Abstract] [Full Text] [Related]

  • 10. Lipid-lowering therapy in acute coronary syndromes.
    Sacks FM.
    JAMA; 2001 Apr 04; 285(13):1758-60. PubMed ID: 11277832
    [No Abstract] [Full Text] [Related]

  • 11. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study.
    Kinlay S, Schwartz GG, Olsson AG, Rifai N, Sasiela WJ, Szarek M, Ganz P, Libby P, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators.
    Circulation; 2004 Jul 27; 110(4):386-91. PubMed ID: 15262833
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes.
    Schwartz GG, Ganz P, Waters D, Arikian S.
    Am J Cardiol; 2003 Nov 01; 92(9):1109-12. PubMed ID: 14583367
    [Abstract] [Full Text] [Related]

  • 14. Statin therapy and the elderly: SAGE advice?
    Gotto AM.
    Circulation; 2007 Feb 13; 115(6):681-3. PubMed ID: 17296867
    [No Abstract] [Full Text] [Related]

  • 15. Atorvastatin: gold standard for prophylaxis of myocardial ischemia and stroke - comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies.
    Gresser U, Gathof BS.
    Eur J Med Res; 2004 Jan 26; 9(1):1-17. PubMed ID: 14766335
    [Abstract] [Full Text] [Related]

  • 16. Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial.
    Schwartz GG, Bessac L, Berdan LG, Bhatt DL, Bittner V, Diaz R, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Mahaffey KW, Moryusef A, Pordy R, Roe MT, Rorick T, Sasiela WJ, Shirodaria C, Szarek M, Tamby JF, Tricoci P, White H, Zeiher A, Steg PG.
    Am Heart J; 2014 Nov 26; 168(5):682-9. PubMed ID: 25440796
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A pharmacoeconomic evaluation of the Myocardial Ischaemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study in the United Kingdom.
    Buller N, Gillen D, Casciano R, Doyle J, Wilson K.
    Pharmacoeconomics; 2003 Nov 26; 21 Suppl 1():25-32. PubMed ID: 12648032
    [Abstract] [Full Text] [Related]

  • 19. Benefits of immediate initiation of statin therapy following successful coronary stent implantation in patients with stable and unstable angina pectoris and Q-wave acute myocardial infarction.
    Walter DH, Fichtlscherer S, Britten MB, Auch-Schwelk W, Schächinger V, Zeiher AM.
    Am J Cardiol; 2002 Jan 01; 89(1):1-6. PubMed ID: 11779513
    [Abstract] [Full Text] [Related]

  • 20. [Effects of statins on coronary artery disease. Review of the recent publications].
    Bednarz B.
    Przegl Lek; 2003 Jan 01; 60(1):27-9. PubMed ID: 12884643
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.